|
|
Volumn 23, Issue 15, 2015, Pages 4884-4890
|
|
Synthesis and bioevaluation of heterocyclic derivatives of Cleistanthin-A
a
a
a
a
a
|
|
Author keywords
Cleistanthin A; Inhibitor; Synthesis; Vacuolar H+ ATPase
|
|
Indexed keywords
4 O [2" O [6 (N MORPHOLINO)HEXYL] 3'' ,4'' DI O METHYL BETA DEXTRO XYLOPYRANOSYL]DIHYLLIN;
4 O [2'' O [6 (N HYDROXYPIPERIDYL)HEXYL] 3'',4'' DI O METHYL BETA DEXTRO XYLOPYRANOSYL]DIPHYLLIN;
4 O [2'' O [6 (N HYDROXYPIPERIDYL)OCTYL] 3'',4'' DI O METHYL BETA DEXTRO XYLOPYRANOSYL]DIPHYLLIN;
4 O [2'' O [6 (N METHYLPIPERAZIN 1 YL)HEXYL] 3'',4'' DI O METHYL BETA DEXTRO XYLOPYRANOSYL]DIPHYLLIN;
4 O [2'' O [6 (N MORPHOLINO)HEXYL] 3'',4'' DI O METHYL BETA DEXTRO XYLOPYRANOSYL]DIHYLLIN;
4 O [2'' O [6 (N PIPERIDINYL)HEXYL] 3'',4'' DI O METHYL BETA DEXTRO XYLOPYRANOSYL]DIPHYLLIN;
4 O [2'' O [6 [N (2 HYDROXYETHYL)PIPERAZIN 1 YL]HEXYL] 3'',4'' DI O METHYL BETA DEXTRO XYLOPYRANOSYL]DIPHYLLIN;
4 O [2'' O [7 (N HYDROXYPIPERIDYL)HEPTYL] 3'',4'' DI O METHYL BETA DEXTRO XYLO PYRANOSYL]DIPHYLLIN;
4 O [2'' O [7 (N METHYLPIPERAZIN 1 YL)HEPTYL] 3'',4'' DI O METHYL BETA DEXTRO XYLOPYRANOSYL]DIPHYLLIN;
4 O [2'' O [7 (N MORPHOLINO)HEPTYL] 3'',4'' DI O METHYL BETA DEXTRO XYLOPYRANOSYL]DIPHYLLIN;
4 O [2'' O [7 [N (2 HYDROXYETHYL)PIPERAZIN 1 YL]HEPTYL] 3'',4'' DI O METHYL BETA DEXTRO XYLOPYRANOSYL]DIPHYLLIN;
4 O [2'' O [8 (N METHYLPIPERAZIN 1 YL)OCTYL] 3'',4'' DI O METHYL BETA DEXTRO XYLO PYRANOSYL]DIPHYLLIN;
4 O [2'' O [8 (N MORPHOLIN)OCTYL] 3'',4'' DI O METHYL BETA DEXTRO XYLOPYRANOSYL]DIPHYLLIN;
4 O [2'' O [8 (N PIPERIDINYL)OCTYL] 3'',4'' DI O METHYL BETA DEXTRO XYLOPYRANOSYL]DIPHYLLIN;
4 O [2'' O [8 [N (2 HYDROXYETHYL)PIPERAZIN 1 YL]OCTYL] 3'',4'' DI O METHYL BETA DEXTRO XYLOPYRANOSYL]DIPHYLLIN;
ANTINEOPLASTIC AGENT;
DIPROPHYLLINE;
PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;
UNCLASSIFIED DRUG;
CLEISTANTHIN;
ENZYME INHIBITOR;
GLYCOSIDE;
LIGNAN;
PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;
A549 CELL LINE;
ANTIPROLIFERATIVE ACTIVITY;
ARTICLE;
CELL PH;
CELL VIABILITY;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG DETERMINATION;
DRUG EFFECT;
DRUG POTENCY;
DRUG SCREENING;
DRUG SELECTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME ASSAY;
ENZYME INHIBITION;
FEMALE;
HCT116 CELL LINE;
HELA CELL LINE;
HEPG2 CELL LINE;
HUMAN;
HUMAN CELL;
IC50;
IN VITRO STUDY;
STRUCTURE ANALYSIS;
ANTAGONISTS AND INHIBITORS;
CELL SURVIVAL;
CHEMISTRY;
DRUG EFFECTS;
METABOLISM;
PH;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
TUMOR CELL LINE;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CELL SURVIVAL;
DRUG SCREENING ASSAYS, ANTITUMOR;
ENZYME INHIBITORS;
GLYCOSIDES;
HEP G2 CELLS;
HUMANS;
HYDROGEN-ION CONCENTRATION;
LIGNANS;
STRUCTURE-ACTIVITY RELATIONSHIP;
VACUOLAR PROTON-TRANSLOCATING ATPASES;
|
|
EID: 84937522712
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2015.05.033 Document Type: Article |
|
Times cited : (12)
|
|
References (15)
|
